Related Experiment Video
Updated: Mar 28, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Positive and problematic support, stress and quality of life in patients with systemic lupus erythematosus
Davide Mazzoni1, Elvira Cicognani1
1a Department of Psychology , University of Bologna , Bologna , Italy.
Background And Objectives:
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Previous studies showed that perceived social support has an important role in enhancing patient's quality of life (QOL). However, the precise mechanisms through which social support exerts such an effect are not completely understood. The aim of this paper is to test two alternative models explaining the relationship between social support (positive and problematic) and two dimensions of QOL: Health-Related (HR-QOL) and Non-Health-Related (NHR-QOL).
Design:
Model A (mediation) hypothesized that positive support would reduce stress while problematic support would increase stress), and that this in turn would reduce QOL. Model B (moderation) hypothesized that the effect of support on QOL would be moderated by the experience of stress in that more stressed individuals would show stronger effects.
Methods:
Three hundred and forty-four Italian patients with SLE completed an online questionnaire.
Results:
Stress partially mediated the relationship between support and QOL dimensions (either HR-QOL and NHR-QOL) thus supporting Model B. As hypothesized, positive support reduced stress, while problematic support increased stress.
Conclusions:
These findings help to explain the complex relationship between social support, stress and QOL in patients with SLE.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Stress Prevention and Stress Management Techniques V
Introduction to Stress and Lifestyle
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Nephrotic Syndrome II : Assessment and Medical Management
COPD: Management Using Bronchodilators and Corticosteroids
